Literature DB >> 8739252

Prevention of late lumen loss after coronary angioplasty by photodynamic therapy: role of activated neutrophils.

W Sluiter1, W J de Vree, A Pietersma, J F Koster.   

Abstract

Restenosis after coronary angioplasty arises from fibrocellular intimal hyperplasia and possibly failure of the artery to enlarge adequately. Which mechanisms underlie this process is only partly understood. No drugs have been clinically effective in reducing the incidence of restenosis. Since recently, photodynamic therapy (PDT) is being investigated as a possible treatment for intimal hyperplasia. PDT involves the systemic administration of a light-excitable photosensitizer that is taken up rather preferentially by rapidly proliferating cells. During laser irradiation light energy is transferred from the photosensitizer to oxygen generating the highly reactive singlet oxygen. This potent oxidizer can cause severe cellular damage. After PDT of a balloon-injured artery from the rat and rabbit the media remained acellular for several weeks to months, and intimal hyperplasia did not occur. The endothelial lining regenerated by two weeks, but why smooth muscle cells did not repopulated the media is not known. Neutrophils seem to play an important role in the prevention of restenosis after coronary angioplasty, since the activation status of this type of phagocyte is directly related to vessel diameter at late follow-up. Furthermore, it has been observed that neutrophils adhere to the microvascular wall upon PDT in vivo. In vitro findings suggest that the increased neutrophil adherence was not dependent on a decreased release of the anti-adhesive factors NO and prostacyclin by the PDT-treated endothelial cells. Furthermore, PDT did not stimulate the expression of P-selectin by the endothelial cells, one of the adhesion receptors for neutrophils. The endothelial cells only retract upon PDT allowing the adherence of neutrophils by their beta 2-integrin adhesion receptors to the subendothelial matrix. On the basis of these findings, we presume that the successful prevention of intimal hyperplasia by PDT partly depends on the presence of the neutrophil at the site of the lesion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739252     DOI: 10.1007/bf00227904

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

Review 1.  A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.

Authors:  J S Forrester; M Fishbein; R Helfant; J Fagin
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

Review 2.  Molecular, cellular, and tissue responses following photodynamic therapy.

Authors:  C J Gomer; A Ferrario; N Hayashi; N Rucker; B C Szirth; A L Murphree
Journal:  Lasers Surg Med       Date:  1988       Impact factor: 4.025

Review 3.  New device angioplasty: the impact on restenosis.

Authors:  C S Wong; M B Leon; J J Popma
Journal:  Coron Artery Dis       Date:  1993-03       Impact factor: 1.439

Review 4.  Prevention of post-PTCA restenosis.

Authors:  D P Faxon; J W Currier
Journal:  Ann N Y Acad Sci       Date:  1995-01-17       Impact factor: 5.691

5.  Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor.

Authors:  M P Hayes; K C Zoon
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Photosensitization of experimental atheromas by porphyrins.

Authors:  M E Pollock; J Eugene; M Hammer-Wilson; M W Berns
Journal:  J Am Coll Cardiol       Date:  1987-03       Impact factor: 24.094

7.  Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits.

Authors:  F Litvack; W S Grundfest; J S Forrester; M C Fishbein; H J Swan; E Corday; D M Rider; I S McDermid; T J Pacala; J B Laudenslager
Journal:  Am J Cardiol       Date:  1985-10-01       Impact factor: 2.778

8.  Photosensitized release of von Willebrand factor from cultured human endothelial cells.

Authors:  T H Foster; M C Primavera; V J Marder; R Hilf; L A Sporn
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

9.  Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment.

Authors:  A Pietersma; M Kofflard; L E de Wit; T Stijnen; J F Koster; P W Serruys; W Sluiter
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

10.  Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro.

Authors:  W J de Vree; A N Fontijne-Dorsman; J F Koster; W Sluiter
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more
  5 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

2.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

Review 3.  Stimulation of anti-tumor immunity by photodynamic therapy.

Authors:  Pawel Mroz; Javad T Hashmi; Ying-Ying Huang; Norbert Lange; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

Review 4.  Photodynamic Therapy and Immunity: An Update.

Authors:  Riddhi Falk-Mahapatra; Sandra O Gollnick
Journal:  Photochem Photobiol       Date:  2020-04-23       Impact factor: 3.421

5.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation.

Authors:  S O Gollnick; S S Evans; H Baumann; B Owczarczak; P Maier; L Vaughan; W C Wang; E Unger; B W Henderson
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.